by abishek | Oct 24, 2025 | Insights, Drug Development, API, Brochures
Introduction PI Health Sciences is your partner for API, intermediate, and KSM manufacturing, from R&D to commercial scale. We offer high-quality, globally compliant solutions. Core Capabilities:> Non-GMP & GMP Manufacturing High Potency (HPAPI) up to OEB4...
by abishek | Oct 24, 2025 | Insights, In Silico Genotoxicity, Brochures
Introduction Ensure reliable and regulatory-aligned genotoxicity testing of drugs with our advanced in silico genotoxicity assessment services. PI Health Sciences uses computational toxicology, (Q)SAR models, and expert interpretation to complement traditional...
by abishek | Oct 24, 2025 | Insights, Immunoenicity, Brochures
Introduction De-risk your synthetic peptide drug products with PI Health Sciences’ comprehensive immunogenicity risk assessment platform. We use advanced in vitro immunogenicity assays with human primary cells to evaluate both innate and adaptive immune responses,...
by abishek | Oct 24, 2025 | Insights, IDD, Discovery Solutions, Brochures
Introduction At PI Health Sciences, we unite artificial intelligence with deep scientific insights in a fully integrated discovery ecosystem. Our AI-powered workflows accelerate every stage of discovery, from target validation to clinical candidate selection, enabling...
by abishek | Oct 24, 2025 | Insights, Brochures
Introduction PI Health Sciences delivers end-to-end pharmaceutical analytical services designed for small-molecule drug substances across all development stages. Our specialized team supports both analytical development and process R&D services with...
by abishek | Sep 2, 2025 | Insights, Discovery Solutions, Blogs
For decades, drug discovery has been notorious for its staggering costs, painfully long timelines, and high attrition rates. On average, developing a new medicine takes 10–15 years and costs upwards of $2 billion. Yet, in the past five years, artificial intelligence...
